These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8353994)

  • 1. Red blood cell and platelet autoantibodies in scleroderma.
    Girelli G; Sorgi ML; Conti L; Arista C; Giacomello A; Gandolfo GM; Zoppini A
    Clin Exp Rheumatol; 1993; 11(3):347-8. PubMed ID: 8353994
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis. Chemotaxis, phagocytosis and opsonized effect of PSS sera on normal granulocytes.
    Sipos A; Czirják L; Lörincz G; Szegedi G
    Scand J Rheumatol; 1988; 17(1):43-50. PubMed ID: 3368751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analytical studies on red blood cell autoantibody and platelet-associated IgG in autoimmune hemolytic anemia and Evans' syndrome].
    Kozuru M; Uike N; Suematsu E; Takahira H; Hisata M
    Rinsho Ketsueki; 1987 Feb; 28(2):169-76. PubMed ID: 3573335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-immunologic shift in systemic scleroderma].
    Drampian FS; Grigorian EG; Aznaurian AV
    Vrach Delo; 1971 Apr; 7():91-4. PubMed ID: 5140143
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-platelet antibodies against gpIIb/IIIa in systemic sclerosis.
    Czirják L; Molnár I; Csipö I; Szabolcs M; Mihály A; Szegedi G
    Clin Exp Rheumatol; 1994; 12(5):527-9. PubMed ID: 7842534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Our observations on intradermal tests with autologous platelets].
    Argenziano G; Rossi A
    G Ital Dermatol Minerva Dermatol; 1969 Oct; 44(10):517-21. PubMed ID: 5408969
    [No Abstract]   [Full Text] [Related]  

  • 7. Red cell, white cell and platelet autoantibodies in visceral leishmaniasis.
    Kager PA; van der Plas-Van Dalen C; Rees PH; Helmerhorst FM; von dem Borne AE
    Trop Geogr Med; 1984 Jun; 36(2):143-50. PubMed ID: 6474559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al.
    Gabrielli A; Moroncini G; Svegliati S; Avvedimento EV
    Arthritis Rheum; 2009 Nov; 60(11):3521-2. PubMed ID: 19877075
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL).
    De Rossi G; Granati L; Girelli G; Gandolo G; Perrone P; Martelli M; Conti L; Marini R; Pastorelli D; Coluzzi S; Niscola P; Pizzo F; Mandeli F
    Tumori; 1991 Apr; 77(2):100-4. PubMed ID: 2048220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
    Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
    J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets in renal scleroderma.
    Amenta PS; Katz SM
    Arch Pathol Lab Med; 1983 Aug; 107(8):439-40. PubMed ID: 6688172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis.
    Bardoni A; Rossi P; Salvini R; Bobbio-Pallavicini F; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2003; 21(3):301-6. PubMed ID: 12846047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 14. Demographic differences in the frequencies of scleroderma-related autoantibodies.
    Picillo U; Migliaresi S; Vatti M; Marcialis MR; Ferruzzi AM; Tirri G
    Arthritis Rheum; 1993 Sep; 36(9):1332-4. PubMed ID: 8216429
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of platelet antibody in Evans syndrome: a case report.
    Kakaiya RM; Sherman LA; Miller WV; Katz AJ
    Ann Clin Lab Sci; 1981; 11(6):511-5. PubMed ID: 7325592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies to collagen type I and fibronectin in patients with scleroderma systemic ].
    Taova MK; Kurdanov KA
    Klin Med (Mosk); 1996; 74(7):50-1. PubMed ID: 8992117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signs of systemic disease in localized scleroderma.
    Czirják L; Ladányi E; Schlammadinger J; Szegedi G
    Arch Dermatol Res; 1991; 283(6):418. PubMed ID: 1796827
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intradermoreaction to autoplatelets in rheumatoid arthritis. Preliminary research].
    Pannuti F; Masiello O
    Arch Patol Clin Med; 1967 Mar; 43(3):185-206. PubMed ID: 5606709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.